Commentary: Abuse of U.S. patent system drives high drug prices
Want Transparent Drug Prices? End Pharma’s Patent Abuse
Submission to FTC on the Role of Intellectual Property
China Patent Challenge Compels Gilead to Withdraw Key Patent Claims on Sofosbuvir Base Compound, Opening Life-Saving Hepatitis C Treatment Access for Millions
Report: Hundreds of Patents on America’s Top Selling Drugs are Triggering Price Hikes and Blocking Competition
I-MAK & Delhi Network of Positive People File Opposition to Prevent AbbVie Patent Grant on Hepatitis C Treatment
The problem with high drug prices isn’t ‘foreign freeloading,’ it’s the patent system
Trump is right: Abusive patents are the culprit behind high drug prices, but his plan doesn’t solve anything
A Supreme Court victory for lowering drug prices
Global Access Expert Rohit Malpani Joins I-MAK’s Growing Team to Solve Drug Patent Problem